Global Infection Control Market will be worth USD 15.8 billion by 2024– New market reports by Data Bridge Market Research

December 12 20:27 2016

“Global Infection Control Market is expected to grow at 6.3% in the forecast period 2017 to 2024”
Global Infection Control Market, By Type (Disinfection (Medical Nonwovens, Disinfectants, Disinfectors (Washer, Flusher, U.V. Rays), Disinfectant Wipes, Endoscope Reprocessors), Sterilization (Products (Heat, Low Temperature, Radiation, Filtration), Services)), By Application, By End-User (Hospitals, Medical Device Manufacturers, Pharmaceutical Manufacturers, Food and Beverage Industry, Laboratory), By Geography – Trends and Forecast to 2024

Global Infection Control Market, By Type (Disinfection (Medical Nonwovens, Disinfectants, Disinfectors (Washer, Flusher, U.V. Rays), Disinfectant Wipes, Endoscope Reprocessors), Sterilization (Products (Heat, Low Temperature, Radiation, Filtration), Services)), By Application, By End-User (Hospitals, Medical Device Manufacturers, Pharmaceutical Manufacturers, Food and Beverage Industry, Laboratory), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2024

Global Infection Control Market is expected to reach USD 15.8 billion by 2024, from USD 9.7 billion in 2016 growing at a CAGR of 6.3% during the forecast period of 2017 to 2024.

Global Infection Control Market is segmented based on basis of type, product type, end-user and geography.

For Sample Report: Global Infection Control Market – Trends and Forecast to 2024

Based on type the infection control market is segmented into disinfection technology and sterilization technologies. The disinfection technology market segment is further categorized on the basis of product type into medical nonwovens, disinfectants, disinfectors, disinfectant wipes and endoscope reprocessor. The sterilization technology market segment is categorized on the basis of type into products and contract services.

To read more about the scope and findings of this report visit: Global Infection Control Market is poised to grow at 6.3% till 2024

On the basis of application the market is further segmented into hand, skin, instruments and surface disinfectants.

Based on end-user the market is further segmented into hospitals, medical device manufacturers, pharmaceutical manufacturers, laboratory, food and beverage industry, and others.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data points for countries like U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.

KEY PLAYERS OPERATING IN GLOBAL INFECTION CONTROL MARKET:

  • 3M Company
  • MMM Group
  • Kimberley-Clark
  • Belimed AG (A Metall Zug Group Company)
  • Cantel Medical Corporation
  • Sterigenics International, Inc.
  • Steris PLC
  • Getinge Group
  • Halyard Health, Inc.
  • Advanced Sterilization Products (A Johnson & Johnson Company)
  • Matachana Group
  • Olympus Corporation
  • Domtar Corporation
  • Medtronic
  • Bio-Cide International, Inc.
  • CareFusion Corporation
  • Molnlycke Health Care AB

To Browse Full Report and Pricing: Global Infection Control Market – Trends and Forecast to 2024

Table of Content:

1          INTRODUCTION

1.1.      OVERVIEW OF THE GLOBAL INFECTION CONTROL MARKET

1.2.      MARKET SEGMENTATION & COVERAGE

1.2.1. CURRENCY AND PRICING 

1.2.2. LIMITATION

1.2.3. STAKEHOLDERS

2          RESEARCH METHODOLOGY

2.1.      KEY TAKEAWAYS

2.2.      ARRIVING AT THE GLOBAL INFECTION CONTROL MARKET SIZE

2.2.1. MARKET CRACKDOWN APPROACH 

2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

2.2.3. DATA TRIANGULATION

2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

2.2.5.  PRODUCT PIPELINE ANALYSIS

2.2.6.  PORTER’S FIVE FORCES MATRIX

2.4.      GLOBAL TOPICAL INFECTION CONTROL MARKET: RESEARCH SNAPSHOT

2.5.      ASSUMPTIONS

3          MARKET LANDSCAPE SUMMARY

4          PREMIUM INSIGHTS

4.1.      OVERVIEW

4.2.      GLOBAL INFECTION CONTROL MARKET: KEY PRIMARY INSIGHTS

4.3.      MARKET OVERVIEW

4.3.1. DRIVERS

            4.3.1.1.   STRINGENT REGULATIONS IN FOOD SAFETY

            4.3.1.2.   INCREASED AWARENESS OF HOSPITAL COMMORBIDITY

            4.3.1.3.   GROWING NUBER OF SURGICAL PROCEDURES

            4.3.1.4.   RISING INCIDENCE OF ICU ACQUIRED INFECTIONS

            4.3.1.5.   RISING INCIDENCE OF ICU ACQUIRED INFECTIONS

            4.3.1.6.   RISING ACCEPTANCE OF HOME HEALTHCARE

            4.3.1.7.   INCREASED AWARENESS OF INFECTION CONTROL IN ASIA

4.3.2. RESTRAINTS

4.3.3. OPPURTUNITIES

4.3.4. THREATS

4.4.      KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

5          EXECUTIVE SUMMARY

6          INFECTION CONTROL MARKET, BY TYPE

6.1.      OVERVIEW

6.2.      DISINFECTION TECHNOLOGY, BY PRODUCT TYPE

6.2.1. MEDICAL NONWOVENS, BY PRODUCT TYPE

            6.2.1.1.  GOWNS

            6.2.1.2.  DRAPES

            6.2.1.3.  WRAPS

            6.2.1.4.  GLOVES

            6.2.1.5.  MASKS

            6.2.1.6.  OTHERS

6.2.2. DISINFECTANTS

            6.2.2.1.  DISINFECTANTS, BY APPLICATION

                            6.2.2.1.1.  HAND

                            6.2.2.1.2.  SKIN

                            6.2.2.1.3.  INSTRUMENT

                            6.2.2.1.4.  SURFACE

            6.2.2.2.  DISINFECTANTS, BY PRODUCT TYPE

                            6.2.2.2.1.  WIPES

                            6.2.2.2.2.  LIQUIDS

                            6.2.2.2.3.  SPRAYS

            6.2.2.3.  DISINFECTANTS, BY ENVIRONMENTAL PROTECTION AGENCY (EPA) CLASSIFICATION

                            6.2.2.3.1.  LOW LEVEL

                            6.2.2.3.2.  INTERMIDIATE LEVEL

                            6.2.2.3.3.  HIGH LEVEL

6.2.3. DISINFECTORS, BY PRODUCT TYPE

            6.2.3.1.  WASHER

                            6.2.3.1.1.  SINGLE CHAMBER

                            6.2.3.1.2.  MULTI CHAMBER

            6.2.3.2.  FLUSHER

            6.2.3.3.  UV RAYS DISINFECTORS

6.2.4. ENDOSCOPIC REPROCESSOR

6.3.      STERILIZATION TECHNOLOGY,

6.3.1. PRODUCTS, BY METHOD TYPE

            6.3.1.1.  HEAT STERILIZATION, BY PRODUCT TYPE

                            6.3.1.1.1.  MOIST HEAT EQUIPMENTS

                            6.3.1.1.2.  DRY HEAT EQUIPMENTS

            6.3.1.2.  LOW TEMPERATURE STERILIZATION, BY PRODUCT TYPE

                            6.3.1.2.1.  ETHYLENE OXIDE STERILIZATION (ETO)

                            6.3.1.2.2.  VAPORIZED HYDROGEN PEROXIDE (VHP)

                            6.3.1.2.3.  HYDROGEN PEROXIDE GAS PLASMA STERILIZATION

                            6.3.1.2.4.  OZONE GAS STERILIZATION

                            6.3.1.2.5.  FORMALDEHYDE STERILIZATION

            6.2.1.3.  RADIATION STERILIZATION

            6.2.1.4.  FILTRATION STERILIZATION

6.3.2. CONTRACT SERVICES, BY SERVICE TYPE

            6.3.2.1.  ETHYLENE OXIDE STERILIZATION SERVICES           

            6.3.2.2.  GAMMA STERILIZATION SERVICES 

            6.3.2.3.  E-BEAM STERILIZATION SERVICES

            6.3.2.4.  OTHERS

7          INFECTION CONTROL MARKET, BY END-USER

7.1.      OVERVIEW

7.2.      HOSPITALS

7.3.      MEDICAL DEVICE MANUFACTURERS

7.4.      PHARMA MANUFACTURERS

7.5.      LABORATORY

7.6.      FOOD AND BEVERAGES

7.6.      OTHERS

8          INFECTION CONTROL MARKET, BY DISTRIBUTION CHANNEL

8.1.      OVERVIEW

8.2.      TENDERS

8.3.      OVER THE COUNTER (OTC)

9          INFECTION CONTROL MARKET, BY GEOGRAPHY

9.1.      COUNTRYWISE INFECTION CONTROL MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

            9.1.1.      NORTH AMERICA

                          9.1.1.1.      U.S.

                          9.1.1.2.      CANADA

                          9.1.1.3.      MEXICO

            9.1.2.      EUROPE

                          9.1.2.1.      GERMANY

                          9.1.2.2.      FRANCE

                          9.1.2.3.      U.K.

                          9.1.2.4.      ITALY

                          9.1.2.5.      SPAIN

                          9.1.2.6.      RUSSIA

                          9.1.2.7.      TURKEY

                          9.1.2.8.      BELGIUM

                          9.1.2.9.      NETHERLANDS

                          9.1.2.10.      SWITZERLAND

                          9.1.2.11.    REST OF EUROPE

            9.1.3.      ASIA-PACIFIC (APAC)

                          9.1.3.1.      JAPAN

                          9.1.3.2.      CHINA

                          9.1.3.3.      SOUTH KOREA

                          9.1.3.4.      INDIA

                          9.1.3.5.      AUSTRALIA

                          9.1.3.6.      SINGAPORE

                          9.1.3.7.      THAILAND

                          9.1.3.8.      MALAYSIA

                          9.1.3.9.      INDONESIA

                          9.1.3.10.      PHILIPPINES

                          9.1.3.11.      REST OF APAC

            9.1.4.    LATIN AMERICA

                          9.1.4.1.     BRAZIL

                          9.1.4.2.     REST OF LATIN AMERICA

            9.1.5.    MIDDLE EAST AND AFRICA

                          9.1.5.1.     SOUTH AFRICA

                          9.1.5.2.     REST OF MIDDLE EAST AND AFRICA

9.2.      KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10        INFECTION CONTROL MARKET: COMPETITIVE LANDSCAPE

10.1.   GLOBAL INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.2.   U.S. INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.3.   EUROPE INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.4.   APAC INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.5.   SOUTH AMERICA INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.6.   MIDDLE EAST AND AFRICA INFECTION CONTROL MARKET: COMPANY SHARE ANALYSIS

10.7.   MERGERS & ACQUISITIONS

10.8.   NEW PRODUCT DEVELOPMENT & APPROVALS

10.10. EXPANSIONS

10.10. REGULATORY CHANGES

10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11        INFECTION CONTROL MARKET, COMPANY PROFILES

11.1    3M COMPANY

                         11.1.1   COMPANY OVERVIEW

                         11.1.2   SWOT ANALYSIS

                         11.1.3   REVENUE ANALYSIS

                         11.1.4   PRODUCT PORTFOLIO

                         11.1.5   RECENT DEVELOPEMENTS

                         11.1.5   DATA BRIDGE ANALYSIS

11.2    MMM GROUP

                         11.2.1   COMPANY OVERVIEW

                         11.2.2   SWOT ANALYSIS

                         11.2.3   REVENUE ANALYSIS

                         11.2.4   PRODUCT PORTFOLIO

                         11.2.5   RECENT DEVELOPEMENTS

                         11.2.5   DATA BRIDGE ANALYSIS

11.3    KIMBERLEY-CLARK

                         11.3.1   COMPANY OVERVIEW

                         11.3.2   SWOT ANALYSIS

                         11.3.3   REVENUE ANALYSIS

                         11.3.4   PRODUCT PORTFOLIO

                         11.3.5   RECENT DEVELOPEMENTS

                         11.3.5   DATA BRIDGE ANALYSIS

11.4    BELIMED AG (A METALL ZUG GROUP COMPANY)

                         11.4.1   COMPANY OVERVIEW

                         11.4.2   SWOT ANALYSIS

                         11.4.3   REVENUE ANALYSIS

                         11.4.4   PRODUCT PORTFOLIO

                         11.4.5   RECENT DEVELOPEMENTS

                         11.4.5   DATA BRIDGE ANALYSIS

11.5    CANTEL MEDICAL CORPORATION

                         11.5.1   COMPANY OVERVIEW

                         11.5.2   SWOT ANALYSIS

                         11.5.3   REVENUE ANALYSIS

                         11.5.4   PRODUCT PORTFOLIO

                         11.5.5   RECENT DEVELOPEMENTS

                         11.5.5   DATA BRIDGE ANALYSIS

11.6    STERIGENICS INTERNATIONAL, INC.

                         11.6.1   COMPANY OVERVIEW

                         11.6.2   SWOT ANALYSIS

                         11.6.3   REVENUE ANALYSIS

                         11.6.4   PRODUCT PORTFOLIO

                         11.6.5   RECENT DEVELOPEMENTS

                         11.6.5   DATA BRIDGE ANALYSIS

11.7    STERIS PLC

                         11.7.1   COMPANY OVERVIEW

                         11.7.2   SWOT ANALYSIS

                         11.7.3   REVENUE ANALYSIS

                         11.7.4   PRODUCT PORTFOLIO

                         11.7.5   RECENT DEVELOPEMENTS

                         11.7.5   DATA BRIDGE ANALYSIS

11.8    GETINGE GROUP

                         11.8.1   COMPANY OVERVIEW

                         11.8.2   SWOT ANALYSIS

                         11.8.3   REVENUE ANALYSIS

                         11.8.4   PRODUCT PORTFOLIO

                         11.8.5   RECENT DEVELOPEMENTS

                         11.8.5   DATA BRIDGE ANALYSIS

11.9    HALYARD HEALTH, INC.

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

11.9    ADVANCED STERILIZATION PRODUCTS (A JOHNSON & JOHNSON COMPANY)

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

11.9    MATACHANA GROUP

                         11.9.1   COMPANY OVERVIEW

                         11.9.2   SWOT ANALYSIS

                         11.9.3   REVENUE ANALYSIS

                         11.9.4   PRODUCT PORTFOLIO

                         11.9.5   RECENT DEVELOPEMENTS

                         11.9.5   DATA BRIDGE ANALYSIS

11.10  OLYMPUS CORPORATION

                         11.10.1   COMPANY OVERVIEW

                         11.10.2   SWOT ANALYSIS

                         11.10.3   REVENUE ANALYSIS

                         11.10.4   PRODUCT PORTFOLIO

                         11.10.5   RECENT DEVELOPEMENTS

                         11.10.5   DATA BRIDGE ANALYSIS

11.11  DOMTAR CORPORATION

                         11.11.1   COMPANY OVERVIEW

                         11.11.2   SWOT ANALYSIS

                         11.11.3   REVENUE ANALYSIS

                         11.11.4   PRODUCT PORTFOLIO

                         11.11.5   RECENT DEVELOPEMENTS

                         11.11.5   DATA BRIDGE ANALYSIS

11.12  MEDTRONIC

                         11.12.1   COMPANY OVERVIEW

                         11.12.2   SWOT ANALYSIS

                         11.12.3   REVENUE ANALYSIS

                         11.12.4   PRODUCT PORTFOLIO

                         11.12.5   RECENT DEVELOPEMENTS

                         11.12.5   DATA BRIDGE ANALYSIS

11.13  BIO-CIDE INTERNATIONAL, INC.

                         11.13.1   COMPANY OVERVIEW

                         11.13.2   SWOT ANALYSIS

                         11.13.3   REVENUE ANALYSIS

                         11.13.4   PRODUCT PORTFOLIO

                         11.13.5   RECENT DEVELOPEMENTS

                         11.13.5   DATA BRIDGE ANALYSIS

11.14  CAREFUSION CORPORATION

                         11.14.1   COMPANY OVERVIEW

                         11.14.2   SWOT ANALYSIS

                         11.14.3   REVENUE ANALYSIS

                         11.14.4   PRODUCT PORTFOLIO

                         11.14.5   RECENT DEVELOPEMENTS

                         11.14.5   DATA BRIDGE ANALYSIS

11.15  MOLNLYCKE HEALTH CARE AB

                         11.15.1   COMPANY OVERVIEW

                         11.15.2   SWOT ANALYSIS

                         11.15.3   REVENUE ANALYSIS

                         11.15.4   PRODUCT PORTFOLIO

                         11.15.5   RECENT DEVELOPEMENTS

                         11.15.5   DATA BRIDGE ANALYSIS

12        APPENDIX

13        ABOUT DATA BRIDGE MARKET RESEARCH

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are one of the largest market research firms in terms of number of reports produced, also we are proud to be the makers of the lengthiest reports in the industry owing to our in depth segmentation and large geographical coverage. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Related Reports:

Global Medical Nonwovens Market – Industry Trends and Forecast to 2024

By Type (Spunbond, Meltblown, Drylaid, SMS, Wetlaid), By Product Type (Hygiene (Incontinence Pads, Ostomy Liners, Disposable Underwear, CSR Wraps, Disposable Medical Wipes, Diapers), Apparel (Surgical Masks, Surgical Packs, Surgical Drapes and Gowns, Surgical Caps, Wound Care), By Usability (Reusable, Disposable), By End-User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Laboratories), By Distribution Channel (Direct Tenders, Retail), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Media Contact
Company Name: Data Bridge Market Research Private Limited
Contact Person: Shubham Dwivedi
Email: Send Email
Phone: +1-888-387-2818
Address:Mega Center, Magarpatta City
City: Pune
State: Maharashtra
Country: India
Website: http://databridgemarketresearch.com/reports/global-infection-control-market-trends-forecast-2024/

  Categories: